Haemonetics Corp at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Well, good morning, everyone, and welcome to day 2 of the Morgan Stanley Healthcare Conference 2020. My name is David Lewis, medical device analyst at Morgan Stanley.
It's my pleasure to start off this morning with Haemonetics. As many of you know, Haemonetics, under the leadership of Chris Simon in these last few years, has really gone through a significant transformation from both a growth technology and cost perspective. We're going to talk about some of that this morning. And then there's been some recent debates on Haemonetics we're also going to focus on as well.
Before we begin, as I've said time and time again, please go to the Morgan Stanley website under Research Disclosures, morganstaley.com/researchdisclosures to see all of my disclosures.
And with that, we're going to get right into it with Chris this morning.
Questions & Answers
So Chris, I want to start sort of with the key debate of the hour.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
